Cognitive Evaluation of Patients With Eating Disorders
Key facts
- Who runs it
- Istituti Clinici Scientifici Maugeri SpA
- Where
- Italy3 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 84 people, planned
- Started
- 26 Nov 2024
- Expected to end
- 31 Mar 2028
- Type of study
- Observational, 3 groups
- Treatments tested
- Go/No-go
- IAT
- WCST
- Record updated
- 16 April 2026
Who can take part
- Age
- 14 years to 65 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 14 criteriaShow less
Who can take part
- Diagnosis of a Feeding and Eating Disorder (ARFID, anorexia nervosa, or bulimia nervosa)
- Patients of both sexes
- Age between 14 and 65 years
- Confirmed diagnosis of a Feeding and Eating Disorder
- Body Mass Index (BMI) < 25
- Signed informed consent form for participation in the study
Who cannot take part
- Diagnosis of Bipolar Disorder according to DSM-5-TR criteria
- Diagnosis of a Schizophrenia Spectrum Disorder according to DSM-5-TR criteria
- History of seizure events
- Presence of other moderate to severe neurological disorders
- Intellectual disability according to DSM-5-TR criteria
- Presence of brain tumors
- Lack of the patient's consent to voluntary participation in the study
- Lack of parental or legal guardian consent for participation of a minor in the study
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 14 and 65 years old?
This trial is currently available in Italy.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this cross - sectional observational study is to improve understanding of the psychological and cognitive characteristics of Feeding and Eating Disorders (FEDs), a group of conditions that represent a growing public health concern due to their significant impact on physical health, emotional well-being, and everyday functioning. Within this broader diagnostic category, particular attention is given to Avoidant/Restrictive Food Intake Disorder (ARFID), a diagnosis introduced in the DSM-5 and still relatively underexplored compared to other feeding and eating disorders.
Read full original descriptionShow less
Despite its clinical relevance, ARFID remains less well understood in terms of its underlying cognitive and psychological mechanisms. Individuals with ARFID often experience severe food avoidance or restriction that is not driven by weight or shape concerns, but rather by sensory sensitivities, fear of negative consequences of eating, or a lack of interest in food. For this reason, investigating ARFID can offer important insights into the diversity of mechanisms involved in feeding and eating disorders as a whole.
The study has two main objectives. The first objective is to examine the cognitive profile of individuals with ARFID, with a specific focus on autistic traits and cognitive flexibility, as previous research suggests potential overlaps between ARFID and neurodevelopmental conditions such as Autism Spectrum Disorders. Cognitive flexibility refers to the ability to adapt thoughts and behaviors in response to changing situations, and reduced flexibility may contribute to rigid eating patterns and food avoidance.
The second objective is to explore the role of body representation (how individuals perceive and mentally represent their own body) and inhibitory control (the ability to regulate or suppress automatic responses) in shaping the cognitive and behavioral features of ARFID and other feeding and eating disorders. These processes may help distinguish ARFID from other diagnoses and clarify shared and disorder-specific mechanisms across the FED spectrum.
The study involves adult participants of all genders, including individuals diagnosed with ARFID, anorexia nervosa, and bulimia nervosa, as well as healthy control participants without a history of feeding or eating disorders. This design allows meaningful comparisons between different diagnostic groups and with the general population.
The main questions the study aims to answer are:
Do individuals with ARFID show a distinct cognitive profile, particularly in terms of autistic traits and cognitive flexibility, compared to individuals with other feeding and eating disorders and healthy controls?
How do body representation and inhibitory control contribute to differences in eating-related behaviors across feeding and eating disorders?
Are there differences in brain activity associated with implicit, automatic attitudes toward food in individuals with feeding and eating disorders compared to healthy individuals?
Where comparison groups are included, researchers will compare participants with ARFID, anorexia nervosa, bulimia nervosa, and healthy controls to examine differences in cognitive functioning, psychological characteristics, and neural responses related to food processing.
Participants will be asked to take part in a series of non-invasive and well-established research activities, designed to be accessible and safe. These include:
Completing self-report questionnaires assessing autistic traits, body image perception, and general psychological well-being;
Performing computer-based tasks that assess cognitive flexibility and decision-making;
Completing behavioral tasks designed to measure inhibitory control and automatic associations with food-related stimuli;
The 3 groups in the trial
- Healthy control
Every participant recieve all the interventions described, each one of them with the specific randomization of subministration.
Treatment: Go/No-go, IAT, and WCST
- ARFID
Patients with Avoidant Restrictive Food Intake Disorder. Every participant recieve all the interventions described, each one of them with the specific randomization of subministration.
Treatment: Go/No-go, IAT, and WCST
- AN/BN
Patients with a diagnosis of Anorexia Nervosa or Bulimia Nervosa. Every participant recieve all the interventions described, each one of them with the specific randomization of subministration.
Treatment: Go/No-go, IAT, and WCST
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Neuro-cognitive Profiles of Patients With Nutritional and Eating Disorders
- Criteria questions
- Built from NCT07478510, who can take part
- Record updated
- 16 April 2026